Basic Research is an herbal supplement and cosmetics manufacturer based in Salt Lake City, Utah that distributes products through a large number of subsidiaries. In addition, their products are sold domestically and internationally through a number of high-end retailers. Dennis Gay is the president and chief executive officer of Basic Research.[1] Basic Research has also been known to conduct business as Silver Sage[2] (2000), and as The Carter-Reed Company[3] (2002).
Subsidiaries of the company include "Basic Research" which markets the sports nutrition products Endothil-CR and Oxydrene. "Zoller Laboratories" markets the Zantrex-3 energy/weight-loss product. "Dynakor Pharmacal" claims to be a Russian company that manufactures the weight-loss products Formula9 and AKAVAR 20/50. These subsidiaries are all housed in the same complex in Salt Lake City and are simply used as a means to market different products to different demographics.
In addition, Basic Research has another subsidiary called "Generix Labs". This company sells the product Striadril, which is billed as a generic version of the StriVectin-SD product at a fraction of the cost. Many customers are not aware that Striadril is exactly the same product as StriVectin-SD, manufactured by exactly the same company, just with a different package and price point to attract a lower-end consumer. Striadril has been discontinued and is no longer available, however, the word Striadril continues to refer to the active ingredients in StriVectin-SD.
On July 10, 2009, the StriVectin family of products [Klein-Becker] were sold to a venture-capital backed company, the Strivectin Operating Company, Inc, to be managed by the Chrysallis Management Group. The new company is based in New York and is not related to Basic Research or any of its affiliates/subsidiaries. The sale affected only the StriVectin products. All other products remained with the Utah-based company.
Several products manufactured by Basic Research, such as Relacore, have come under scrutiny by the FDA for making claims that cannot be substantiated or that would place the product under FDA regulation as a drug.[4] [5] [6] [7]